Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. (Q37953819)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

polycystic ovary syndrome

16 January 2020

main subject

1 reference

1 reference

1 reference

Héctor Escobar Morreale

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Didier Dewailly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Robert J Norman

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

E Carmina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Gambineri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

F Kelestimur

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

P Moghetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

M Pugeat

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Qiao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

C N Wijeyaratne

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

S F Witchel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

6 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

Human Reproduction Update

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

146-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

WNT signals are required for the initiation of hair follicle development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Adrenarche - physiology, biochemistry and human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The prevalence and features of the polycystic ovary syndrome in an unselected population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Cyproterone acetate for severe hirsutism:results of a double-blind dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Psychological morbidity in women referred for treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Finasteride versus cyproterone acetate-estrogen regimens in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Androgen production in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

21 January 2018

Mild androgen phenotypes

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Hepatotoxicity during low-dose flutamide treatment for hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Long-term safety and tolerability of flutamide for the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Hormones and the pilosebaceous unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

High prevalence of polycystic ovary syndrome in women with mild hirsutism and no other significant clinical symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The hair cycle and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Diagnosis and management of hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

At the roots of a never-ending cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

TYPES AND DISTRIBUTION OF THE HAIR IN MAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Evidence-based review of hair removal using lasers and light sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Dynamics between stem cells, niche, and progeny in the hair follicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The effect of eflornithine 13.9% cream on the bother and discomfort due to hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The effect of metformin on hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A very large proportion of young Danish women have polycystic ovaries: is a revision of the Rotterdam criteria needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Best practice options for hair removal in patients with unwanted facial hair using combination therapy with laser: guidelines drawn up by an expert working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Circadian clock genes contribute to the regulation of hair follicle cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Adrenal and gonadal androgen secretion in normal females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Variations in pattern of pubertal changes in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Lack of effect of spironolactone on hair shaft diameter in hirsute females

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Androgen synthesis in adrenarche

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Familial study of hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Prevalence of polycystic ovary syndrome and related disorders in mexican women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

In search of the "hair cycle clock": a guided tour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Clinical utility of sex hormone-binding globulin measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Androgens and hair growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Electrolysis: observations from 13 years and 140,000 hours of experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Effect of daily and alternate day low dose prednisone on serum cortisol and adrenal androgens in hirsute women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Clinical practice. Hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

An extraordinarily inaccurate assay for free testosterone is still with us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Toward excellence in testosterone testing: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Laser hair reduction in the hirsute patient: a critical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The hair follicle as a dynamic miniorgan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Quality of life of hirsute women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The prevalence of androgen excess among patients with minimal unwanted hair growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Glucocorticoid therapy in hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A detailed investigation of hirsutism in a Turkish population: idiopathic hyperandrogenemia as a perplexing issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13.9% cream in the treatment of women with facial hair

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Visually scoring hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Epidemiologic and etiologic aspects of hirsutism in Kashmiri women in the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

Long-Term Efficacy and Tolerability of Flutamide Combined with Oral Contraception in Moderate to Severe Hirsutism: A 12-Month, Double-Blind, Parallel Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMR042

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMR042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22064667%20AND%20SRC:MED&resulttype=core&format=json

release_rayjcfdf6zebvjgobka66n4uty

16 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rayjcfdf6zebvjgobka66n4uty

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference